36.61

4.01% 1.41

After Hours: 36.95 0.34 +0.93%

Liquidia Corp (LQDA)

Overview News Price History Option Chain Financials Discussions Forecast

Liquidia Corp stock is traded at $36.61, with a volume of 1.02M. It is up +4.01% in the last 24 hours and up +22.03% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Previous Close:

$35.20

Open:

$35.57

24h Volume:

1.02M

Relative Volume:

0.57

Market Cap:

$3.23B

Revenue:

$158.32M

Net Income/Loss:

$-68.92M

P/E Ratio:

-44.02

EPS:

-0.8317

Net Cash Flow:

$-40.02M

1W Performance:

-0.05%

1M Performance:

+22.03%

6M Performance:

+63.07%

1Y Performance:

+134.68%

1-Day Range:

$35.57

$37.43

1-Week Range:

$34.21

$37.59

52-Week Range:

$11.26

$46.67

Liquidia Corp Stock (LQDA) Company Profile

Name

Liquidia Corp

Sector

Healthcare (1114)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

919.328.4400

Address

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Employee

216

Twitter

@Liquidia_Inc

Next Earnings Date

2026-03-05

Latest SEC Filings

LQDA's Discussions on Twitter

Compare LQDA vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LQDA Liquidia Corp	36.61	3.10B	158.32M	-68.92M	-40.02M	-0.8317
TAK Takeda Pharmaceutical Co Adr	18.29	56.99B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	116.71	48.94B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.74	43.30B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	29.46	33.94B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	541.60	23.31B	3.18B	1.33B	1.04B	27.90

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-15-25	Resumed	Jefferies	Buy
May-19-25	Downgrade	Oppenheimer	Perform → Underperform
Dec-20-24	Initiated	Wells Fargo	Overweight
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy
Sep-19-22	Resumed	Wedbush	Underperform
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform
Jul-22-22	Initiated	Ladenburg Thalmann	Buy
May-31-22	Initiated	BTIG Research	Buy
May-26-22	Initiated	BofA Securities	Buy
Dec-04-20	Initiated	H.C. Wainwright	Buy
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform
Aug-20-18	Initiated	Jefferies	Buy
Aug-20-18	Initiated	Needham	Buy

View All

Liquidia Corp Stock (LQDA) Latest News

Mar 25, 2026

Aug Sectors: Is Liquidia Corporation stock influenced by commodity prices2026 Risk Factors & High Accuracy Buy Signal Tips - baoquankhu1.vn

Mar 22, 2026

Mar 19, 2026

Liquidia Corporation $LQDA Shares Sold by Mirabella Financial Services LLP - MarketBeat

Mar 19, 2026

Liquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA Nod - MSN

Mar 19, 2026

Mar 18, 2026

Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Mar 18, 2026

Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High? - Yahoo Finance

Mar 18, 2026

Liquidia (NASDAQ:LQDA) Announces Quarterly Earnings Results, Beats Estimates By $0.14 EPS - MarketBeat

Mar 18, 2026

Mar 17, 2026

Why Liquidia (LQDA) Is Down 5.1% After Swing to Profit and $125 Million Shelf Filings - Yahoo Finance

Mar 17, 2026

Recent Insider Transactions at Liquidia Corp - TradingView

Mar 17, 2026

Liquidia (LQDA) CMO trims stake with 35,365-share open-market sale - Stock Titan

Mar 17, 2026

Liquidia (LQDA) HR chief sells 16,261 shares, keeps 148,397 - Stock Titan

Mar 17, 2026

Liquidia (LQDA) director sells 20,000 shares after exercising options - Stock Titan

Mar 17, 2026

Mar 16, 2026

Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget

Mar 16, 2026

Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail

Mar 16, 2026

Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN

Mar 16, 2026

Farallon Capital Management LLC Purchases 4,326,876 Shares of Liquidia Corporation $LQDA - MarketBeat

Mar 16, 2026

Mar 15, 2026

Liquidia (LQDA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 15, 2026

Mar 13, 2026

Rule 144: LQDA (NASDAQ) notice lists 40,359-share planned sale - Stock Titan

Mar 13, 2026

Rajeev Saggar sells 21,142 LQDA shares (NASDAQ: LQDA) reported on Form 144 - Stock Titan

Mar 13, 2026

Insider Sale Notices at LQDA: 13,165-Share Disposition and Issuer Awards (LQDA) - Stock Titan

Mar 13, 2026

Mar 12, 2026

Assessing Liquidia (LQDA) Valuation After Strong Earnings And YUTREPIA Driven Momentum - simplywall.st

Mar 12, 2026

Oppenheimer Forecasts Strong Price Appreciation for Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Mar 12, 2026

Oppenheimer Raises Price Target for LQDA While Maintaining 'Unde - GuruFocus

Mar 12, 2026

Mar 11, 2026

Liquidia (NASDAQ: LQDA) CCO sells 80K shares after option exercise - Stock Titan

Mar 11, 2026

Liquidia Corp (NASDAQ:LQDA) Shows High-Growth Momentum and Minervini Trend Alignment - ChartMill

Mar 11, 2026

Liquidia Stock (+8.3%): Analyst Upgrades & Media Praise Overpower EPS Miss - Trefis

Mar 11, 2026

Mar 10, 2026